Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

212
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
212
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

163
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
163
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

180
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
180
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Acanthamoeba spp. from water and soil of public parks in the north of Iran.

Journal of water and health·2022
Same author

Evaluation of the efficacy of different concentrations of nano-capsules containing Talaromyces flavus with two forms of powder and suspension in reducing the incidence of cotton Verticillium wilt.

Brazilian journal of biology = Revista brasleira de biologia·2022
Same author

The impact of differential expression of the pectoral muscle proteome in two groups of Japanese quail with different growth rates on‏ meat quality.

British poultry science·2020
Same author

Impact of the Iranian Registry of Infective Endocarditis (IRIE) and multidisciplinary team approach on patient management.

Acta cardiologica·2020
Same author

Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria.

European annals of allergy and clinical immunology·2019
Same author

Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.

Journal de mycologie medicale·2019

Related Experiment Video

Updated: Dec 12, 2025

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.1K

Inherited thrombophilia in mechanical valve malfunction.

S Saedi1, R Yazzaf1, M Parsaee2

  • 1Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

Annales De Cardiologie Et D'Angeiologie
|August 11, 2020
PubMed
Summary
This summary is machine-generated.

Thrombophilia gene mutations are common in patients with mechanical pulmonary valve thrombosis, even with adequate anticoagulation. This suggests genetic factors significantly contribute to this life-threatening complication.

Keywords:
GeneticGénétiqueProsthetic heart valveThrombophiliaThrombophilieThromboseThrombosisValve cardiaque prothétique

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.0K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.2K

Related Experiment Videos

Last Updated: Dec 12, 2025

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.1K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.0K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.2K

Area of Science:

  • Cardiology
  • Genetics
  • Thrombosis Research

Background:

  • Mechanical heart valves can malfunction due to thrombosis, a serious complication.
  • Adequate anticoagulation is crucial but doesn't always prevent thrombosis in prosthetic valves.

Purpose of the Study:

  • To determine the prevalence of thrombophilia genes in patients with acute mechanical pulmonary valve thrombosis.
  • To assess the role of genetic predisposition in thrombosis despite therapeutic anticoagulation.

Main Methods:

  • Cross-sectional comparative study involving 32 patients with acute mechanical pulmonary valve thrombosis.
  • Assessed International Normalized Ratio (INR) levels and screened for mutations in thrombophilia factor genes.

Main Results:

  • 75% of patients (24/32) exhibited thrombophilia gene mutations.
  • Common mutations included Plasminogen activator inhibitor-1 (PAI-I) at 50% and Methylenetetrahydrofolate Reductase (MTHFR) at 37.5%.
  • Prevalence of these mutations was higher than in the general population.

Conclusions:

  • Thrombophilia gene mutations are highly prevalent in patients experiencing mechanical pulmonary valve thrombosis.
  • Genetic factors likely play a significant role in the development of thrombosis, necessitating further investigation into personalized anticoagulation strategies.